Es gab 50 kürzliche Insider-Transaktionen für AVROBIO, Inc. (AVRO), darunter 39 Käufe und 9 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.93M und die gesamten Insider-Verkäufe auf $303.13K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Leonard Braden Michael, Avruch Steven, Ostrowski Erik. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AVRO
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
Informierter Kauf |
296,882 |
$1.30 |
$385.95K |
4,768,262 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
Unbekannt |
- |
- |
- |
4,471,380 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
Informierter Kauf |
253,700 |
$1.24 |
$313.32K |
4,255,327 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
Veräußerung |
- |
- |
- |
400,000 |
| 2024-02-05 |
Avruch Steven |
Chief Legal Officer |
RSU-Steuereinbehalt |
10,812 |
$1.20 |
$13K |
22,022 |
| 2024-02-05 |
Ostrowski Erik |
Interim CEO, President and CFO |
RSU-Steuereinbehalt |
13,099 |
$1.20 |
$15.74K |
29,285 |
| 2024-02-05 |
Ridha Essra |
Chief Medical Officer |
RSU-Steuereinbehalt |
16,953 |
$1.20 |
$20.35K |
15,881 |
| 2024-02-05 |
Golipour Azadeh |
Chief Technology Officer |
RSU-Steuereinbehalt |
12,232 |
$1.20 |
$14.7K |
55,872 |
| 2024-02-01 |
Avruch Steven |
Chief Legal Officer |
Optionsausübung |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
Optionsausübung |
40,084 |
- |
- |
42,384 |
| 2024-02-01 |
Ridha Essra |
Chief Medical Officer |
Optionsausübung |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Golipour Azadeh |
Chief Technology Officer |
Optionsausübung |
37,334 |
- |
- |
68,104 |
| 2023-07-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
RSU-Zuteilung |
70,000 |
- |
- |
70,000 |
| 2023-06-12 |
Golipour Azadeh |
Chief Technology Officer |
RSU-Steuereinbehalt |
111 |
$1.21 |
$133.76 |
30,770 |
| 2023-06-06 |
Donenberg Phillip B. |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Clark Ian T |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Booth Bruce |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Farfel Gail M |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Vickers Philip J. |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Jenkins Annalisa |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Paige Christopher |
Director |
RSU-Zuteilung |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-02-08 |
Petersen Deanna M |
Chief Business Officer |
RSU-Zuteilung |
86,667 |
- |
- |
86,667 |
| 2023-02-08 |
Mackay Geoffrey |
President & CEO |
RSU-Zuteilung |
300,667 |
- |
- |
300,667 |
| 2023-02-08 |
Avruch Steven |
Chief Legal Officer |
RSU-Zuteilung |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Ostrowski Erik |
Chief Financial Officer |
RSU-Zuteilung |
160,333 |
- |
- |
160,333 |
| 2023-02-08 |
Ridha Essra |
Chief Medical Officer |
RSU-Zuteilung |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Golipour Azadeh |
Chief Technology Officer |
RSU-Zuteilung |
149,333 |
- |
- |
149,333 |
| 2023-01-24 |
Mackay Geoffrey |
President & CEO |
Optionsausübung (Verkauf) |
45,999 |
- |
- |
- |
| 2022-12-28 |
Mackay Geoffrey |
President & CEO |
Schenkung (gegeben) |
245,123 |
- |
- |
142,013 |
| 2022-12-23 |
Mackay Geoffrey |
President & CEO |
Optionsausübung (Verkauf) |
142,013 |
- |
- |
- |
| 2022-12-08 |
Petersen Deanna M |
Chief Business Officer |
RSU-Zuteilung |
111,500 |
- |
- |
111,500 |
| 2022-12-08 |
Mackay Geoffrey |
President & CEO |
RSU-Zuteilung |
388,000 |
- |
- |
388,000 |
| 2022-12-08 |
Avruch Steven |
Chief Legal Officer |
RSU-Zuteilung |
169,500 |
- |
- |
169,500 |
| 2022-12-08 |
Ostrowski Erik |
Chief Financial Officer |
RSU-Zuteilung |
221,000 |
- |
- |
221,000 |
| 2022-12-08 |
Ridha Essra |
Chief Medical Officer |
RSU-Zuteilung |
183,000 |
- |
- |
183,000 |
| 2022-12-08 |
Golipour Azadeh |
Chief Technology Officer |
RSU-Zuteilung |
165,000 |
- |
- |
165,000 |
| 2022-06-08 |
Donenberg Phillip B. |
Director |
RSU-Zuteilung |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Clark Ian T |
Director |
RSU-Zuteilung |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Booth Bruce |
Director |
RSU-Zuteilung |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Farfel Gail M |
Director |
RSU-Zuteilung |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Vickers Philip J. |
Director |
RSU-Zuteilung |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Jenkins Annalisa |
Director |
RSU-Zuteilung |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Paige Christopher |
Director |
RSU-Zuteilung |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Golipour Azadeh |
Chief Technology Officer |
Veräußerung |
130,000 |
$1.84 |
$239.2K |
- |
| 2022-02-02 |
Petersen Deanna M |
Chief Business Officer |
RSU-Zuteilung |
80,000 |
$1.84 |
$147.2K |
80,000 |
| 2022-02-02 |
Mackay Geoffrey |
President & CEO |
RSU-Zuteilung |
328,500 |
$1.84 |
$604.44K |
328,500 |
| 2022-02-02 |
Avruch Steven |
Chief Legal Officer |
RSU-Zuteilung |
90,000 |
$1.84 |
$165.6K |
90,000 |
| 2022-02-02 |
Ostrowski Erik |
Chief Financial Officer |
RSU-Zuteilung |
145,000 |
$1.84 |
$266.8K |
145,000 |
| 2022-02-02 |
Ridha Essra |
Chief Medical Officer |
RSU-Zuteilung |
75,000 |
$1.84 |
$138K |
75,000 |
| 2021-11-01 |
Ridha Essra |
Chief Medical Officer |
RSU-Zuteilung |
120,000 |
$5.67 |
$680.4K |
120,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
